We are live on ! Find out more
VIA

Virtus Investment Advisers Portfolio holdings

AUM $363M
1-Year Est. Return 34.89%
This Fund
S&P 500
This Quarter Est. Return
-1.68%
1 Year Est. Return
+34.89%
3 Year Est. Return
+131.43%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$368M
AUM Growth
+$240M
Cap. Flow
+$255M
Cap. Flow %
69.4%
Top 10 Hldgs %
25.49%
Holding
710
New
414
Increased
42
Reduced
13
Closed
237

Top Buys

Rank Stock Value
1
VABS icon
Virtus Newfleet ABS/MBS ETF
VABS
+$32.2M
2
VSHY icon
Virtus Newfleet Short Duration High Yield Bond ETF
VSHY
+$24.8M
3
SEIX icon
Virtus SEIX Senior Loan ETF
SEIX
+$19.2M
4
SMC
Summit Midstream
SMC
+$4.35M
5
OCCI
OFS Credit Co
OCCI
+$2.75M

Top Sells

Rank Stock Value
1
IBN icon
ICICI Bank
IBN
+$3.75M
2
VCLN icon
Virtus Duff & Phelps Clean Energy ETF
VCLN
+$2.74M
3
AAPL icon
Apple
AAPL
+$2.06M
4
MSFT icon
Microsoft
MSFT
+$2.02M
5
PRIM icon
Primoris Services
PRIM
+$1.86M

Sector Composition

Rank Sector Weight
1 Financials 24.48%
2 Healthcare 11.95%
3 Technology 8.6%
4 Industrials 8.02%
5 Energy 4.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BBIO icon
201
BridgeBio Pharma
BBIO
$16.5B
$449K 0.12%
+12,978
New +$438K
AXSM icon
202
Axsome Therapeutics
AXSM
$10.9B
$444K 0.12%
+3,806
New +$434K
GILD icon
203
Gilead Sciences
GILD
$165B
$439K 0.12%
+3,920
New +$404K
ASND icon
204
Ascendis Pharma A/S
ASND
$16.8B
$428K 0.12%
+2,747
New +$392K
MSDL icon
205
Morgan Stanley Direct Lending Fund
MSDL
$1.3B
$422K 0.11%
+21,135
New +$437K
SWTX
206
DELISTED
SpringWorks Therapeutics
SWTX
$409K 0.11%
+9,279
New +$427K
AMGN icon
207
Amgen
AMGN
$222B
$408K 0.11%
+1,309
New +$387K
ALNY icon
208
Alnylam Pharmaceuticals
ALNY
$29.3B
$396K 0.11%
+1,467
New +$377K
KNSA icon
209
Kiniksa Pharmaceuticals
KNSA
$5.93B
$396K 0.11%
+17,828
New +$367K
MDGL icon
210
Madrigal Pharmaceuticals
MDGL
$11.8B
$394K 0.11%
+1,188
New +$390K
PTCT icon
211
PTC Therapeutics
PTCT
$6.12B
$386K 0.11%
+7,583
New +$378K
BMRN icon
212
BioMarin Pharmaceuticals
BMRN
$12.4B
$383K 0.1%
+5,416
New +$364K
MIRM icon
213
Mirum Pharmaceuticals
MIRM
$6.14B
$383K 0.1%
+8,492
New +$400K
ADMA icon
214
ADMA Biologics
ADMA
$2.22B
$382K 0.1%
19,230
+4,250
+28% +$73.5K
INSM icon
215
Insmed
INSM
$28.6B
$380K 0.1%
+4,986
New +$381K
EXEL icon
216
Exelixis
EXEL
$13.4B
$377K 0.1%
10,209
-2,791
-21% -$99.4K
VRTX icon
217
Vertex Pharmaceuticals
VRTX
$126B
$375K 0.1%
+773
New +$360K
HRMY icon
218
Harmony Biosciences
HRMY
$2.24B
$374K 0.1%
11,268
+7,668
+213% +$275K
KRYS icon
219
Krystal Biotech
KRYS
$9.66B
$373K 0.1%
+2,068
New +$348K
TARS icon
220
Tarsus Pharmaceuticals
TARS
$2.84B
$361K 0.1%
+7,025
New +$347K
TVTX icon
221
Travere Therapeutics
TVTX
$5.78B
$359K 0.1%
+20,046
New +$407K
DVAX
222
DELISTED
Dynavax Technologies
DVAX
$358K 0.1%
+27,636
New +$366K
IBRX icon
223
ImmunityBio
IBRX
$8.1B
$355K 0.1%
+118,100
New +$358K
BCRX icon
224
BioCryst Pharmaceuticals
BCRX
$2.4B
$354K 0.1%
+47,239
New +$381K
IMCR icon
225
Immunocore
IMCR
$1.73B
$352K 0.1%
+11,847
New +$355K
7 8
9
10 11

Similar funds

RC
Reik & Co New York $363M AUM 3.03% 1-Year Est. Return
MS
Millington Securities Red Bank, New Jersey $362M AUM
WI
WBI Investments Red Bank, New Jersey $362M AUM 23.75% 1-Year Est. Return
HS
HighVista Strategies Boston, Massachusetts $362M AUM 230.96% 1-Year Est. Return
SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
A6
Anchor @ 65 Singapore $362M AUM 20.02% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return

Virtus Investment Advisers's Q1 2025 Portfolio in Review

As of Q1 2025, Virtus Investment Advisers held 710 positions worth $368M, up 188% from $128M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Virtus Investment Advisers deployed $255M of net new capital in Q1 2025, opening 414 new positions and adding to 42 existing holdings. Its largest new stake was Virtus Newfleet ABS/MBS ETF: 1,321,000 shares worth $32.2M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Berry Corp, an estimated $666K trimmed.

  • Virtus Investment Advisers's largest Q1 2025 buy was Virtus Newfleet ABS/MBS ETF: 1,321,000 shares worth $32.2M.
  • Virtus Investment Advisers added most to Yum China in Q1 2025, an estimated $1.42M increase.
  • Virtus Investment Advisers's biggest Q1 2025 reduction was Berry Corp, cutting an estimated $666K.
  • Virtus Investment Advisers fully exited ICICI Bank in Q1 2025, selling an estimated $3.75M.
  • Virtus Investment Advisers's ten largest holdings make up 25% of its $368M portfolio in Q1 2025.
  • Virtus Investment Advisers opened 414 new positions and closed 237 in Q1 2025.
  • Virtus Investment Advisers's portfolio value rose 188% quarter-over-quarter to $368M.

Based on Virtus Investment Advisers's 13F filing for Q1 2025, filed 15 May 2025.